CBD, Cannabidiol Market Anticipated To Grow At A Lucrative

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
400
CBD, Cannabidiol Market Anticipated To Grow At A Lucrative Rate Through 2027 As Consumer Demand Rapidly Increases


PALM BEACH, Fla., May 12, 2021 /PRNewswire/ -- Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost production for CBD-infused products. Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health.


Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in the pharmaceutical sector. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand. According to reports from Grand View Research the global cannabidiol; market size is expected to reach USD 13.4 billion by 2028, and is expected to expand at a CAGR of 21.2% from 2021 to 2028.


The report said: "Increasing awareness about the health benefits of cannabidiol (CBD), changing consumer opinion, and attitude toward CBD products are some of the key factors driving the demand for these products. Furthermore, increasing demand for cannabidiol from various end-user industries such as food and beverage, personal care and cosmetics, and pharmaceuticals is expected to trigger market growth…" One of the coming giants can be; HempFusion Wellness Inc. (TSX:CBD-U.TO) (OTCQX:CBDHF)



The Grand View Research report continued with: "In 2020, the hemp segment accounted for the largest revenue share valued at USD 1.7 billion, owing to the rising awareness regarding the health benefits of products infused with cannabidiol derived from marijuana. On the other hand, hemp-derived CBD is expected to witness the fastest CAGR over the forecast period, owing to the increasing legalization of hemp in various countries. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products.


Read More: https://investorshangout.com/post/view?id=620...z72NfMOpSs
Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 36

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 36

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 44

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 36

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 42

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 29

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 46

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Alcoa Corporation Surges Amidst Market Uncertainties and Earnings

Updated Category News Views 193

Alcoa Corporation's Financial Performance Amid Market Fluctuations In today's unpredictable market, Alcoa Corporation (NYSE: AA) has emerged with financial insights reflecting the ongoing changes in the aluminum industry. Their recent quarter showed some fluctuations, offering a valuable perspective on how they are navigating these challenges. Impressive Revenue Figures...

Continue Reading
BCE's Preferred Shares Conversion Unpacks Investor Moves

Updated Category News Views 5

Exploring BCE's Preferred Share Shift Some days it's just about reading between the lines of corporate moves. Today, BCE Inc., that giant of the North you've probably caught a quote or two from on the TSX as BCE, tossed out a fresh update. And it ain't just any old news—the conversion of preferred shares from Series AJ to Series AI, to be exact. If you're shaking your...

Continue Reading
Trump Administration Freezes NYC Infrastructure Funds Amid Controversy

Updated Category News Views 314

Trump's Decision to Withhold NYC Infrastructure Funding The Trump administration has recently made a significant decision to withhold $18 billion in federal funds from New York City. This decision particularly affects two major infrastructure projects that are vital for enhancing transportation. Impact on Major Transportation Projects The funds in question are intended...

Continue Reading
Rosen Law Firm Initiates Class Action for Moderna Shareholders

Updated Category News Views 120

Class Action Lawsuit Against Moderna, Inc. Rosen Law Firm, a respected global investor rights law firm, is bringing attention to a class action lawsuit filed on behalf of all individuals who purchased securities of Moderna, Inc. (NASDAQ: MRNA) through a specified timeframe. Moderna is a biotechnology leader recognized for discovering and commercializing messenger RNA...

Continue Reading
Toll Brothers: A 20-Year Investment That Paid Off

Updated Category News Views 64

Exploring Toll Brothers' Investment Growth Toll Brothers (NYSE: TOL) has shown impressive growth in the stock market, consistently outperforming many competitors for the past two decades. Investors who made a modest investment in TOL two decades ago have enjoyed substantial returns. The average annualized return is currently at 9.4%, underscoring the company's success in...

Continue Reading